PHI with Intracranial venous sinus thrombosis
How does this condition affect your private health insurance?
Intracranial Venous Sinus Thrombosis (CVST) is a rare form of stroke caused by a blood clot in the brain's venous sinuses, which drain blood from the brain. Unlike arterial strokes, CVST can affect multiple brain areas and present with a wide range of symptoms, including severe headache, seizures, focal neurological deficits, altered mental status, and even coma. Risk factors include genetic clotting disorders, oral contraceptives, pregnancy, puerperium, infections, and certain medical conditions. Diagnosis typically involves MRI with venography or CT venography. Treatment primarily involves anticoagulation to prevent clot propagation and promote recanalization, along with supportive care to manage symptoms.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to weeks for acute hospitalization and initial treatment, followed by 3-12 months of anticoagulation.
Duration of Illness (Lifetime)
Typically a one-time event with resolution, but long-term anticoagulation may be necessary for recurrent risk factors. Residual symptoms (e.g., headaches) can be chronic in some cases.
Cost of Treatment (Initial)
High (e.g., $20,000 - $100,000+) due to hospitalization, advanced imaging, medication, and potential intensive care.
Cost of Treatment (Lifetime)
Variable, from moderate (follow-up appointments, medication costs for 3-12 months or longer) to very high if severe neurological deficits require ongoing rehabilitation and long-term care.
Mortality Rate
Approximately 5-15%, depending on severity, underlying causes, and treatment efficacy.
Risk of Secondary Damages
Significant (30-50% probability) including persistent headaches, seizures, focal neurological deficits (e.g., weakness, sensory loss), or cognitive impairment.
Probability of Full Recovery
Good (60-80% probability) with early diagnosis and appropriate treatment, leading to complete or near-complete recovery without significant lasting consequences.
Underlying Disease Risk
High (80-90% probability) of associated risk factors such as genetic thrombophilias, malignancy, systemic inflammatory diseases, infections, pregnancy/puerperium, or oral contraceptive use.